141 results
Page 5 of 8
8-K
EX-99.1
ldygiu2cz 0g7zh
23 Apr 13
LifeMap Sciences, a Subsidiary of BioTime, Announces Partnership with Appistry
12:00am
8-K
EX-99
jsz hweek2xlx8
19 Apr 13
BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke
12:00am
8-K
EX-99.1
0sgswckwgvmk r4mw832
10 Apr 13
LifeMap Sciences Adds Products Through Partnership with ProSpec-Tany TechnoGene
12:00am
8-K
EX-99.1
048wm
25 Mar 13
Regulation FD Disclosure
12:00am
8-K
EX-99.1
q09odjq3
18 Mar 13
BioTime Announces Fourth Quarter and Fiscal Year End 2012 Financial Results and Recent Corporate Accomplishments
12:00am
8-K
EX-99.1
p0fa 6ekqlunebj
13 Mar 13
BioTime to Present at 25th Annual ROTH Conference
12:00am
8-K
EX-99.1
6r764a
12 Mar 13
BioTime Appoints Stephen C. Farrell to Board of Directors
12:00am
DEFA14A
EX-99.1
7cjqmj7t1m v28
7 Mar 13
Additional proxy soliciting materials
12:00am
8-K
EX-99.1
71bher2y3bz4lb 4b
7 Mar 13
BioTime and Romulus Agree to Accelerate Closing Date for Second Tranche of $5 Million Financing
12:00am
8-K
EX-99.1
u16habv 9ow
4 Mar 13
BioTime and Subsidiary LifeMap Sciences Announce Data Mining Collaboration
12:00am
8-K
EX-99.1
75beb
11 Feb 13
Regulation FD Disclosure
12:00am
8-K
EX-99.1
7prni
31 Jan 13
BioTime’s Subsidiary OncoCyte Corporation Provides an Update on the Development of the Novel Pan-Cancer Diagnostic Product PanC-DxTM
12:00am
8-K
EX-99.1
k4pu 9xhb29qp5t0
30 Jan 13
Regulation FD Disclosure
12:00am
8-K
EX-99.1
ohts1qbfnsb9fr0o
9 Jan 13
LifeMap Sciences, a Subsidiary of BioTime, Inc., Announces the Release of MalaCards Version 1.02
12:00am
8-K
EX-99.1
3yog0ak3em16
27 Nov 12
Regulation FD Disclosure
12:00am
8-K
EX-99.1
t5hmtl so8emmf
20 Nov 12
LifeMap Sciences, a Subsidiary of BioTime, Signs Definitive Distribution Agreement with ProSpec-Tany TechnoGene
12:00am